Six months after initiation of SIT , we recorded a reduction in cell surface CD40L expression in the CD4 + T-cell population and a shift in the cytokine production profile ( decrease in IL-4-producing CD4 + T cells and increase in IFN-gamma , IL-10 , and TGF-beta1 ) .